lorazepam has been researched along with oxazepam in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 45 (40.18) | 18.7374 |
1990's | 27 (24.11) | 18.2507 |
2000's | 22 (19.64) | 29.6817 |
2010's | 14 (12.50) | 24.3611 |
2020's | 4 (3.57) | 2.80 |
Authors | Studies |
---|---|
Babbini, M; Barbaro, AM; Bartoletti, M; Biagi, GL; Borea, PA; Gaiardi, M; Guerra, MC | 1 |
Johnston, GA; Maddalena, DJ | 1 |
Karplus, M; So, SS | 1 |
Coassolo, P; Lavé, T; Schneider, G | 1 |
Strassburg, CP; Tukey, RH | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Abdelkafi, H; Ait Ouarab, L; Barbier, J; Buisson, DA; Caramelle, L; Cintrat, JC; Clerget, A; Gillet, D; Michau, A; Montoir, D; Ngadjeua, F; Pons, V | 1 |
Aliverti, V; Mariani, L | 1 |
Greenblatt, DJ; Shader, RI | 3 |
Kozlovskaia, MM; Val'dman, AV | 1 |
Hoyumpa, AM | 1 |
Schenker, S | 1 |
Wilkinson, GR | 1 |
Higuchi, S; Shiobara, Y; Urabe, H | 1 |
Airoldi, L; Bianchi, R; Chiabrando, C; Fanelli, R; Frigerio, A; Garattini, S; Marcucci, F; Mussini, E; Salmona, M | 1 |
Hagberg, G; Laegreid, L; Lundberg, A | 1 |
Loeffler, PM | 1 |
Lewis, DC; Sullivan, JT; Swift, RM | 1 |
Daubländer, M; Lipp, M | 1 |
Krsiak, M; Sulcova, A | 1 |
Greenblatt, DJ; Sethy, VH | 1 |
Bertucci, C; Domenici, E; Salvadori, P; Wainer, IW | 1 |
File, SE; Mabbutt, PS; Wilks, LJ | 1 |
Fiumara, AM; Kearsley, JH; Williams, AM | 1 |
Busto, U; Cappell, H; Naranjo, CA; Sanchez-Craig, M; Sellers, EM; Sykora, K | 1 |
Curran, HV; Lader, M; Schiwy, W | 1 |
Bareggi, SR; Ferrario, P; Pirola, R; Zecca, L | 1 |
File, SE; Wilks, LJ | 1 |
Bond, A; Lader, M | 1 |
Clark, BJ; Fell, AF; Mama, JE; Noctor, TA | 1 |
Fogelson, DL | 1 |
Saha, UK; Sengupta, D | 1 |
Martin, WR; McNicholas, LF; Pruitt, TA | 1 |
Fitos, I; Lagercrantz, C; Larsson, T; Simonyi, M; Sjöholm, I; Tegyey, Z | 1 |
Desmond, PV; Johnson, RF; Patwardhan, RV; Schenker, S; Speeg, KV; Yarborough, GW | 1 |
Auvinen, J; Lamminsivu, U; Linnoila, M; Viukari, M | 1 |
Lapierre, YD | 1 |
Ruffalo, RL; Segal, JL; Thompson, JF | 1 |
Vozeh, S | 1 |
Divoll, M; Greenblatt, DJ; Shader, RI | 1 |
Lukovits, I; Maksay, G; Otvös, L; Simon-Trompler, E; Volford, J | 1 |
Kanto, JH | 1 |
Carskadon, M; Dement, W; Seidel, W | 1 |
Berthe, J; Gouy, D; Mazue, G; Remandet, B; Roncucci, R; Williams, GM | 1 |
Fitos, I; Kajtár, J; Kajtár, M; Simonyi, M | 1 |
Abernethy, DR; Divoll, M; Greenblatt, DJ; Harmatz, JS; Ochs, HR; Shader, RI; Weyers, D | 1 |
MacKinnon, GL; Parker, WA | 1 |
Abernethy, DR; Divoll, M; Greenblatt, DJ; Shader, RI | 1 |
Fasching, I; Haubenstock, A; Hruby, K; Jäger, U | 1 |
Johnson, HD; Male, CG | 1 |
Olive, G; Rey, E | 1 |
Abernethy, DR; Greenblatt, DJ; Koepke, HH; Shader, RI | 1 |
Abernethy, DR; File, SE; Greenblatt, DJ; Lister, RG | 1 |
Divoll, M; Greenblatt, DJ; Harmatz, JS; Shader, RI | 1 |
Fitos, I; Otvös, L; Simonyi, M; Tegyey, Z | 1 |
Boonkerd, S; Detaevernier, MR; Michotte, Y; Vindevogel, J | 1 |
Needleman, SB; Porvaznik, M | 1 |
Cohen, SI | 1 |
Belal, F; Hefnawy, MM; Metwally, ME; Walash, MI | 1 |
Chosson, E; Farinotti, R; Gimenez, F; Uzan, S; Wainer, IW | 1 |
Curran, HV; Gorenstein, C | 1 |
Friedman, LS; Mayo-Smith, MF; Saitz, R | 1 |
Chauvet, A | 1 |
Goldstein, MZ; Pataki, A; Webb, MT | 1 |
Connolly, JF; Dunphy, SC; Rioux, GF; Stewart, SH; Teehan, MD | 1 |
Mersch, F; Wennig, R; Yegles, M | 1 |
Buffett-Jerrott, SE; Stewart, SH; Teehan, MD | 1 |
Ackermann, I; Angermaier, L; Deinl, I; Franzelius, C; Machbert, G | 1 |
Deuschle, M; Drancoli, J; Heuser, I; Schmider, J; Standhart, H | 1 |
Miller, KE; Prater, CD; Zylstra, RG | 1 |
Altieri, I; Pacifici, R; Palmeri, A; Pellegrini, M; Pichini, S; Zuccaro, P | 1 |
Böhmer, C; Centelles, JJ; Kinne, RK; Palmada, M | 1 |
Schoetz, G; Schurig, V; Trapp, O | 1 |
Bhatnagar, MK; Jain, A | 1 |
Bournique, JS; Dou, C; Gnezda, M; McNally, AJ; Salamone, SJ; Zinda, MK | 1 |
O'Neal, CL; Poklis, A | 1 |
Alexander, J; Daniels, B; Kirkby, KC; Martin, F; Martin, J; Matthews, A | 1 |
Chikhi-Chorfi, N; Claude, JR; Galons, H; Hua, H; Pham-Huy, C; Thevenin, M; Villain-Pautet, G; Warnet, JM | 1 |
Pfendt, LB; Popović, GV; Sladić, DM; Stefanović, VM | 1 |
de Leon, J | 1 |
Berkovic, SF; Granot, R; Hopwood, M; Mackenzie, R; Patterson, S | 1 |
He, H; Liu, Y; Pham-Huy, C; Sun, C; Wang, X | 1 |
Chen, J; Fitos, I; Hage, DS | 1 |
Hou, J; Rizvi, SA; Shamsi, SA; Zheng, J | 1 |
Billiot, E; Billiot, F; Warner, IM | 1 |
Chronister, CW; Goldberger, BA; Merves, ML | 1 |
Gunn, J; Kriger, S; Terrell, AR | 1 |
Ahmad, F; Amanlou, M; Ataie, G; Hakimelahi, GH; Khalafi-Nezhad, A; Moosavi-Movahedi, AA; Poursasan, N; Saboury, AA; Sepassi Tehrani, H; Sharifizadeh, A; Soltani Rad, MN; Tsai, FY | 1 |
Begg, EJ; Chin, PK; Jensen, BP; Larsen, HS | 2 |
Marin, SJ; McMillin, GA; Roberts, M; Wood, M | 1 |
Bosy, T; Holler, J; Malik-Wolf, B; Vorce, S | 1 |
Gogol, M; Hartmann, H; Simm, A; Wustmann, S | 1 |
Chester, SA; McIntire, GL; Morris, AA; Strickland, EC | 1 |
Mangelings, D; Muscat Galea, C; Vander Heyden, Y | 1 |
Chaslot, M; Delage, M; Dulaurent, S; El Balkhi, S; Mathieu, O; Picard, N; Saint-Marcoux, F | 1 |
Falcon, M; Fernadez-Lopez, L; Luna, A; Mancini, R; Pellegrini, M; Rotolo, M | 1 |
Docci, L; Fowler, S; Krähenbühl, S; Parrott, N; Umehara, K | 1 |
Coulter, C; Garnier, M; Moore, C | 1 |
12 review(s) available for lorazepam and oxazepam
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oral benzodiazepines and conscious sedation: a review.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Conscious Sedation; Diazepam; Flurazepam; Humans; Lorazepam; Midazolam; Oxazepam; Premedication; Receptors, GABA-A; Temazepam; Triazolam | 1992 |
Diazepam-cimetidine drug interaction: a clinically significant effect.
Topics: Anti-Anxiety Agents; Cimetidine; Cytochrome P-450 Enzyme System; Depression, Chemical; Diazepam; Drug Interactions; Guanidines; Humans; Kinetics; Lorazepam; Oxazepam; Oxidation-Reduction | 1981 |
Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations.
Topics: Anti-Anxiety Agents; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Female; Flunitrazepam; Humans; Infant, Newborn; Labor, Obstetric; Lactation; Lorazepam; Maternal-Fetal Exchange; Nitrazepam; Oxazepam; Pregnancy | 1982 |
Benzodiazepine withdrawal syndrome: a literature review and evaluation.
Topics: Anti-Anxiety Agents; Chlordiazepoxide; Diazepam; Dose-Response Relationship, Drug; Humans; Lorazepam; Nitrazepam; Oxazepam; Substance Withdrawal Syndrome; Substance-Related Disorders; Temazepam; Time Factors | 1982 |
The use of benzodiazepines in clinical practice.
Topics: Anti-Anxiety Agents; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Humans; Kinetics; Lorazepam; Metabolic Clearance Rate; Oxazepam; Prazepam; Substance Withdrawal Syndrome | 1981 |
[Benzodiazepines and pregnancy. Transplacental passage, labor and lactation].
Topics: Anti-Anxiety Agents; Biotransformation; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Female; Flunitrazepam; Humans; Kinetics; Lorazepam; Maternal-Fetal Exchange; Milk, Human; Nitrazepam; Oxazepam; Postpartum Period; Pregnancy | 1983 |
Alcoholism among elderly persons.
Topics: Aged; Alcoholism; Benzodiazepines; Contraindications; Disulfiram; Humans; Incidence; Lorazepam; Mental Disorders; Oxazepam; Patient Education as Topic; Risk Factors | 1996 |
Outpatient detoxification of the addicted or alcoholic patient.
Topics: Alcohol Withdrawal Delirium; Alcoholic Intoxication; Ambulatory Care; Anti-Anxiety Agents; Chlordiazepoxide; Diagnosis, Differential; Drug Administration Schedule; Drug Interactions; Humans; Hypnotics and Sedatives; Lorazepam; Oxazepam; Patient Education as Topic; Phenobarbital; Severity of Illness Index; Substance-Related Disorders; Surveys and Questionnaires; Teaching Materials | 1999 |
Glucuronidation enzymes, genes and psychiatry.
Topics: Animals; Glucuronosyltransferase; Humans; Lorazepam; Oxazepam; Polymorphism, Genetic; Psychiatry; Serotonin | 2003 |
11 trial(s) available for lorazepam and oxazepam
Article | Year |
---|---|
Antiemetic superiority of lorazepam over oxazepam and methylprednisolone as premedicants for patients receiving cisplatin-containing chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Female; Humans; Lorazepam; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasms; Oxazepam; Vomiting | 1989 |
Withdrawal reaction after long-term therapeutic use of benzodiazepines.
Topics: Adolescent; Adult; Aged; Anxiety; Benzodiazepines; Diazepam; Double-Blind Method; Female; Flurazepam; Humans; Long-Term Care; Lorazepam; Male; Middle Aged; Oxazepam; Patient Compliance; Placebos; Substance Withdrawal Syndrome; Time Factors | 1986 |
Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives.
Topics: Adult; Arousal; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Lorazepam; Male; Memory; Mental Recall; Metabolic Clearance Rate; Middle Aged; Oxazepam; Problem Solving; Psychomotor Performance | 1987 |
Differential effects of oxazepam and lorazepam on aggressive responding.
Topics: Adult; Aggression; Anxiety; Emotions; Female; Humans; Lorazepam; Male; Middle Aged; Oxazepam; Reaction Time | 1988 |
Efficacy and side effects of lorazepam, oxazepam, and temazepam as sleeping aids in psychogeriatric inpatients.
Topics: Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lorazepam; Mental Disorders; Oxazepam; Sleep; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Temazepam | 1980 |
Oral benzodiazepine premedication in minor gynaecological surgery.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Benzodiazepinones; Clinical Trials as Topic; Clobazam; Diazepam; Double-Blind Method; Female; Flicker Fusion; Humans; Lorazepam; Mental Recall; Middle Aged; Oxazepam; Preanesthetic Medication; Reaction Time; Sleep Stages; Surgical Procedures, Operative | 1984 |
Differential effects of lorazepam and oxazepam on priming.
Topics: Adolescent; Adult; Analysis of Variance; Double-Blind Method; Female; Humans; Lorazepam; Male; Memory; Mental Recall; Oxazepam; Psychological Tests | 1993 |
Effects of oxazepam and lorazepam on implicit and explicit memory: evidence for possible influences of time course.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Double-Blind Method; Female; Humans; Lorazepam; Male; Memory; Oxazepam; Time Factors | 1996 |
A further examination of the time-dependent effects of oxazepam and lorazepam on implicit and explicit memory.
Topics: Adult; Analysis of Variance; Attention; Cognition Disorders; Conscious Sedation; Cues; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Mental Recall; Motion Pictures; Oxazepam; Psychomotor Performance; Time Factors | 1998 |
A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism.
Topics: Adult; Aged; Anti-Anxiety Agents; Brief Psychiatric Rating Scale; Catatonia; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Mutism; Oxazepam; Psychomotor Performance; Severity of Illness Index | 1999 |
Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Anxiety Agents; Double-Blind Method; Female; Humans; Learning; Lorazepam; Memory, Short-Term; Mental Recall; Oxazepam; Pain Measurement; Perception; Psychological Tests; Psychomotor Performance; Reaction Time; Thiamine | 2002 |
89 other study(ies) available for lorazepam and oxazepam
Article | Year |
---|---|
Rm values and structure-activity relationship of benzodiazepines.
Topics: Animals; Benzodiazepines; Chromatography, Thin Layer; Conflict, Psychological; Exploratory Behavior; Models, Biological; Rats; Solubility; Structure-Activity Relationship | 1980 |
Prediction of receptor properties and binding affinity of ligands to benzodiazepine/GABAA receptors using artificial neural networks.
Topics: Binding Sites; Ligands; Neural Networks, Computer; Predictive Value of Tests; Receptors, GABA-A; Structure-Activity Relationship | 1995 |
Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors.
Topics: Algorithms; Benzodiazepines; Models, Genetic; Nerve Net; Protein Binding; Receptors, GABA-A; Structure-Activity Relationship | 1996 |
Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques.
Topics: Animals; Biological Availability; Dogs; Humans; Least-Squares Analysis; Liver; Multivariate Analysis; Neural Networks, Computer; Pharmacokinetics; Rats | 1999 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin.
Topics: Benzodiazepinones; Golgi Apparatus; HeLa Cells; Humans; Protein Transport; Shiga Toxins; Structure-Activity Relationship | 2020 |
[Therapeutic notes: benzodiazepines].
Topics: Anti-Anxiety Agents; Chemical Phenomena; Chemistry; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Flurazepam; Humans; Lorazepam; Nitrazepam; Oxazepam | 1976 |
Clinical implications of benzodiazepine pharmacokinetics.
Topics: Administration, Oral; Adult; Age Factors; Aged; Alcoholism; Anti-Anxiety Agents; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Drug Interactions; Humans; Injections, Intramuscular; Injections, Intravenous; Intestinal Absorption; Liver; Lorazepam; Medazepam; Oxazepam | 1977 |
[Psychophysiologic characteristics of the individual psychotropic activity of benzodiazepine derivatives under experimental conditions].
Topics: Animals; Anti-Anxiety Agents; Anxiety; Cats; Chlordiazepoxide; Diazepam; Humans; Lorazepam; Neurotic Disorders; Nitrazepam; Oxazepam; Stress, Psychological | 1978 |
Disposition and elimination of minor tranquilizers in the aged and in patients with liver disease.
Topics: Aged; Aging; Anti-Anxiety Agents; Chlordiazepoxide; Diazepam; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Lorazepam; Oxazepam | 1978 |
Effects of liver disease and of aging on the disposition and elimination of sedatives.
Topics: Aging; Anti-Anxiety Agents; Chlordiazepoxide; Chlorpromazine; Diazepam; Half-Life; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Diseases; Lorazepam; Meprobamate; Oxazepam | 1978 |
The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man.
Topics: Administration, Oral; Adult; Aged; Aging; Anti-Anxiety Agents; Chlordiazepoxide; Diazepam; Female; Half-Life; Hepatitis, Viral, Human; Humans; Injections, Intravenous; Liver Cirrhosis, Alcoholic; Liver Diseases; Lorazepam; Male; Middle Aged; Oxazepam | 1978 |
Simplified determination of lorazepam and oxazepam in biological fluids by gas chromatography-mass spectrometry.
Topics: Anti-Anxiety Agents; Gas Chromatography-Mass Spectrometry; Humans; Lorazepam; Oxazepam | 1979 |
Benzodiazepines: some aspects of their clinical pharmacology.
Topics: Anti-Anxiety Agents; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Humans; Lorazepam; Oxazepam; Prazepam | 1979 |
Gas chromatographic-mass spectrometric determination of intact C3-hydroxylated benzodiazepine glucoronides in urine.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Chromatography, Gas; Glucuronates; Guinea Pigs; Humans; Hydroxylation; Lorazepam; Male; Mass Spectrometry; Oxazepam; Rabbits; Rats; Trimethylsilyl Compounds | 1975 |
Neurodevelopment in late infancy after prenatal exposure to benzodiazepines--a prospective study.
Topics: Abnormalities, Drug-Induced; Anti-Anxiety Agents; Arousal; Body Height; Body Weight; Cephalometry; Diazepam; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infant; Longitudinal Studies; Lorazepam; Male; Motor Activity; Neurologic Examination; Oxazepam; Pregnancy; Prenatal Exposure Delayed Effects; Prospective Studies; Psychomotor Performance; Risk Factors | 1992 |
Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale.
Topics: Administration, Oral; Adult; Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Chlordiazepoxide; Diazepam; Hospitalization; Humans; Length of Stay; Lorazepam; Neurologic Examination; Oxazepam; Retrospective Studies; Temazepam; Triazolam | 1991 |
[Premedication and analgesic dose procedures in dental medicine].
Topics: Anesthesia, Dental; Anesthesia, Local; Buprenorphine; Clorazepate Dipotassium; Diazepam; Flunitrazepam; Humans; Lorazepam; Meperidine; Midazolam; Morphine; Oxazepam; Pain; Pentazocine; Pirinitramide; Preanesthetic Medication | 1991 |
Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice.
Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Clonazepam; Lorazepam; Male; Mice; Motor Activity; Nitrazepam; Oxazepam; Shyness; Structure-Activity Relationship; Triazolam | 1990 |
Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam.
Topics: Animals; Anti-Anxiety Agents; Brain; Chromatography, Gas; Diazepam; Half-Life; Hydroxylation; Injections, Intravenous; Lorazepam; Male; Mice; Oxazepam; Receptors, GABA-A | 1990 |
Use of a human serum albumin-based high-performance liquid chromatography chiral stationary phase for the investigation of protein binding: detection of the allosteric interaction between warfarin and benzodiazepine binding sites.
Topics: Allosteric Regulation; Allosteric Site; Benzodiazepines; Chromatography, High Pressure Liquid; Humans; Lorazepam; Oxazepam; Protein Binding; Serum Albumin; Stereoisomerism; Warfarin | 1991 |
The role of the benzodiazepine receptor in mediating long-lasting anticonvulsant effects and the late-appearing reductions in motor activity and exploration.
Topics: Animals; Anticonvulsants; Exploratory Behavior; Lorazepam; Male; Mice; Motor Activity; Oxazepam; Pentylenetetrazole; Receptors, GABA-A; Seizures; Time Factors | 1989 |
Analysis of chlorodesmethyldiazepam and its metabolites in plasma and urine.
Topics: Anti-Anxiety Agents; Benzodiazepines; Chromatography, Gas; Diazepam; Glucuronates; Humans; Lorazepam; Nordazepam; Oxazepam | 1987 |
Does the behavioural activation detected after a single dose of a benzodiazepine reflect a withdrawal response?
Topics: Animals; Behavior, Animal; Benzodiazepines; Flumazenil; Lorazepam; Male; Mice; Motor Activity; Oxazepam | 1988 |
Computer-aided optimisation of drug enantiomer separation in chiral high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Lorazepam; Microcomputers; Oxamniquine; Oxazepam; Software; Stereoisomerism; Temazepam | 1988 |
Lorazepam and oxazepam in the treatment of panic disorder.
Topics: Adult; Drug Therapy, Combination; Fear; Female; Humans; Lorazepam; Male; Oxazepam; Panic | 1988 |
In vitro effects of oxazepam, lorazepam & chlordiazepoxide on the cholinesterase activity of human foetal & adult brain.
Topics: Abortion, Induced; Adult; Brain; Chlordiazepoxide; Cholinesterases; Fetal Organ Maturity; Fetus; Humans; Lorazepam; Oxazepam | 1987 |
N-desmethyldiazepam physical dependence in dogs.
Topics: Analysis of Variance; Animals; Body Weight; Diazepam; Dogs; Drinking; Energy Intake; Female; Lorazepam; Muscle Spasticity; Nordazepam; Oxazepam; Paresthesia; Substance Withdrawal Syndrome; Temazepam; Time Factors | 1985 |
Stereoselective binding of 3-acetoxy-, and 3-hydroxy-1,4-benzodiazepine-2-ones to human serum albumin. Selective allosteric interaction with warfarin enantiomers.
Topics: Benzodiazepines; Diazepam; Humans; Lorazepam; Oxazepam; Research Design; Serum Albumin; Stereoisomerism; Structure-Activity Relationship; Ultrafiltration; Warfarin | 1986 |
Cimetidine spares the glucuronidation of lorazepam and oxazepam.
Topics: Adult; Anti-Anxiety Agents; Biotransformation; Cimetidine; Drug Interactions; Female; Glucuronates; Guanidines; Humans; Lorazepam; Male; Oxazepam | 1980 |
Benzodiazepine withdrawal.
Topics: Anti-Anxiety Agents; Anxiety; Diazepam; Drug Tolerance; Humans; Lorazepam; Oxazepam; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors | 1981 |
[Pharmacokinetic of benzodiazepines in old age].
Topics: Adult; Aged; Aging; Anti-Anxiety Agents; Chlordiazepoxide; Diazepam; Half-Life; Humans; Lorazepam; Metabolic Clearance Rate; Middle Aged; Nitrazepam; Nordazepam; Oxazepam | 1981 |
Kinetics of oxazepam and lorazepam in two subjects with Gilbert syndrome.
Topics: Adult; Anti-Anxiety Agents; Gilbert Disease; Humans; Hyperbilirubinemia, Hereditary; Kinetics; Lorazepam; Male; Oxazepam | 1981 |
Lorazepam and oxazepam esters. Hydrophobicity, hydrolysis rates and brain appearance.
Topics: Animals; Anti-Anxiety Agents; Blood-Brain Barrier; Brain; Chemistry, Pharmaceutical; Esters; Hydrolysis; Kinetics; Lorazepam; Male; Mice; Oxazepam | 1982 |
Daytime alertness, insomnia, and benzodiazepines.
Topics: Adult; Anti-Anxiety Agents; Arousal; Benzodiazepines; Double-Blind Method; Flurazepam; Humans; Lorazepam; Male; Oxazepam; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazolam; Wakefulness | 1982 |
Limited in vivo bioassays on some benzodiazepines: lack of experimental initiating or promoting effect of the benzodiazepine tranquillizers diazepam, clorazepate, oxazepam and lorazepam.
Topics: 2-Acetylaminofluorene; Animals; Anti-Anxiety Agents; Biological Assay; Carcinogens; Clorazepate Dipotassium; Diazepam; Lorazepam; Male; Oxazepam; Rats; Rats, Inbred F344; Time Factors | 1982 |
Application of ultrafiltration and CD spectroscopy for studying stereoselective binding of racemic ligands.
Topics: Anti-Anxiety Agents; Binding Sites; Circular Dichroism; Humans; Isomerism; Kinetics; Ligands; Lorazepam; Mathematics; Oxazepam; Protein Binding; Serum Albumin; Ultrafiltration | 1982 |
Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
Topics: Adult; Anti-Anxiety Agents; Contraceptives, Oral; Female; Humans; Kinetics; Lorazepam; Metabolic Clearance Rate; Oxazepam | 1983 |
Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.
Topics: Acetaminophen; Adult; Aged; Anti-Anxiety Agents; Female; Glucuronates; Humans; Lorazepam; Male; Middle Aged; Obesity; Oxazepam | 1983 |
[Comparative clinical toxicology of 5 benzodiazepine derivatives].
Topics: Adult; Anti-Anxiety Agents; Bromazepam; Child; Coma; Diazepam; Dose-Response Relationship, Drug; Female; Flunitrazepam; Humans; Lorazepam; Male; Metabolic Clearance Rate; Oxazepam; Prognosis; Respiratory Insufficiency; Suicide, Attempted | 1984 |
Interaction of cimetidine with oxazepam, lorazepam, and flurazepam.
Topics: Adult; Anti-Anxiety Agents; Biotransformation; Cimetidine; Female; Flurazepam; Half-Life; Humans; Kinetics; Lorazepam; Male; Microsomes, Liver; Oxazepam | 1984 |
Methods for the determination of lorazepam and chlordiazepoxide and metabolites in brain tissue. A comparison with plasma concentrations in the rat.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Brain; Chlordiazepoxide; Lorazepam; Male; Oxazepam; Rats | 1983 |
Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines.
Topics: Benzodiazepines; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Flurazepam; Humans; Lorazepam; Medazepam; Nitrazepam; Oxazepam; Safety; Substance Withdrawal Syndrome; Substance-Related Disorders; Temazepam; Triazolam | 1980 |
Oxazepam kinetics: effects of age and sex.
Topics: Adult; Age Factors; Aged; Female; Half-Life; Humans; Intestinal Absorption; Kinetics; Lorazepam; Male; Middle Aged; Oxazepam; Protein Binding; Sex Factors; Smoking | 1980 |
Stationary ultrafiltration: a radio-tracer technique for studying stereoselective binding of racemic ligands.
Topics: Carbon Radioisotopes; Humans; Ligands; Lorazepam; Oxazepam; Pharmaceutical Preparations; Protein Binding; Salicylates; Serum Albumin; Stereoisomerism; Structure-Activity Relationship; Tritium; Ultrafiltration | 1980 |
Suppression of chiral recognition of 3-hydroxy-1,4-benzodiazepines during micellar electrokinetic capillary chromatography with bile salts.
Topics: Anti-Anxiety Agents; Benzodiazepines; Bile Acids and Salts; Capillary Action; Chromatography; Kinetics; Lorazepam; Micelles; Oxazepam; Temazepam | 1995 |
Identification of parent benzodiazepines by gas chromotography/mass spectroscopy (GC/MS) from urinary extracts treated with B-glucuronidase.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Clonazepam; Diazepam; Gas Chromatography-Mass Spectrometry; Glucuronidase; Humans; Lorazepam; Oxazepam; Triazolam | 1995 |
Alcohol and benzodiazepines generate anxiety, panic and phobias.
Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Female; Humans; Lorazepam; Male; Middle Aged; Oxazepam; Panic Disorder; Phobic Disorders; Substance Withdrawal Syndrome | 1995 |
A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3.
Topics: Anti-Anxiety Agents; Benzodiazepines; Fluorometry; Humans; Hydroxyl Radical; Lorazepam; Magnetic Resonance Spectroscopy; Mass Spectrometry; Oxazepam; Oxidation-Reduction; Temazepam | 1994 |
Influence of specific albumin ligand markers used as modifiers on the separation of benzodiazepine enantiomers by chiral liquid chromatography on a human serum albumin column.
Topics: Anti-Anxiety Agents; Chromatography, Affinity; Chromatography, Liquid; Humans; Ligands; Lorazepam; Oxazepam; Serum Albumin; Stereoisomerism; Temazepam; Warfarin | 1993 |
Alcohol withdrawal: a nationwide survey of inpatient treatment practices.
Topics: Adrenergic beta-Antagonists; Alcoholism; Barbiturates; Benzodiazepines; Chlordiazepoxide; Clonidine; Data Collection; Diazepam; Drug Administration Schedule; Hypnotics and Sedatives; Inpatients; Lorazepam; Oxazepam; Phenytoin; Substance Withdrawal Syndrome | 1995 |
[Characterization of lorazepam and oxazepam by the thermal behavior of their degradation product].
Topics: Anti-Anxiety Agents; Calorimetry, Differential Scanning; Hot Temperature; Lorazepam; Oxazepam; Thermogravimetry | 1995 |
Detection of benzodiazepines and other psychotropic drugs in human hair by GC/MS.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Drug Overdose; Female; Flunitrazepam; Gas Chromatography-Mass Spectrometry; Hair; Humans; Lorazepam; Male; Middle Aged; Oxazepam; Psychotropic Drugs | 1997 |
Simultaneous extraction of selected benzodiazepines and benzodiazepine-glucuronides from urine by immunoadsorption.
Topics: Anti-Anxiety Agents; Diazepam; Glucuronates; Humans; Immunosorbent Techniques; Immunosorbents; Lorazepam; Oxazepam; Temazepam | 1998 |
Determination of lorazepam in plasma and urine as trimethylsilyl derivative using gas chromatography-tandem mass spectrometry.
Topics: Anti-Anxiety Agents; Gas Chromatography-Mass Spectrometry; Humans; Lorazepam; Oxazepam; Reference Standards | 1999 |
Effect of benzodiazepines on the epithelial and neuronal high-affinity glutamate transporter EAAC1.
Topics: Amino Acid Transport System X-AG; Animals; Anti-Anxiety Agents; Binding Sites; Carrier Proteins; CHO Cells; Clozapine; Cricetinae; Cricetulus; Diazepam; Epithelial Cells; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Ion Transport; Lorazepam; Medazepam; Nerve Tissue Proteins; Neurons; Oocytes; Oxazepam; Recombinant Fusion Proteins; Sodium; Symporters; Xenopus laevis | 1999 |
Dynamic micellar electrokinetic chromatography. Determination of the enantiomerization barriers of oxazepam, temazepam, and lorazepam.
Topics: Algorithms; Anti-Anxiety Agents; Chromatography, Micellar Electrokinetic Capillary; Computer Simulation; Lorazepam; Oxazepam; Stereoisomerism; Temazepam | 2000 |
Changing trends of poisoning at railway stations.
Topics: Humans; India; Lorazepam; Oxazepam; Railroads; Travel | 2000 |
Comparison of the rates of hydrolysis of lorazepam-glucuronide, oxazepam-glucuronide and tamazepam-glucuronide catalyzed by E. coli beta-D-glucuronidase using the on-line benzodiazepine screening immunoassay on the Roche/Hitachi 917 analyzer.
Topics: Anti-Anxiety Agents; Escherichia coli; Forensic Medicine; Glucuronidase; Glucuronides; Humans; Hydrogen-Ion Concentration; Hydrolysis; Immunoassay; Lorazepam; Oxazepam; Temazepam; Temperature; Urinalysis | 2001 |
Commentary on: Dou C, Bournique J, Zinda M, Gnezda M, Nally A, Salamone S. Comparison of rates of hydrolysis of lorazepam-glucuronide, oxazepam-glucuronide and temazepam-glucuronide catalyzed by E. coli beta-glucuronidase using the on-line benzodiazepine
Topics: Benzodiazepines; Escherichia coli; Glucuronidase; Humans; Hydrolysis; Immunoassay; Lorazepam; Oxazepam; Temazepam | 2002 |
Separation of oxazepam, lorazepam, and temazepam enantiomers by HPLC on a derivatized cyclodextrin-bonded phase: application to the determination of oxazepam in plasma.
Topics: Animals; Benzodiazepinones; Chromatography, High Pressure Liquid; Cyclodextrins; Lorazepam; Optical Rotation; Oxazepam; Quality Control; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Temazepam | 2002 |
Study on protolytic equilibria of lorazepam and oxazepam by UV and NMR spectroscopy.
Topics: Lorazepam; Magnetic Resonance Spectroscopy; Oxazepam; Spectrophotometry, Ultraviolet | 2003 |
Idiopathic recurrent stupor: a warning.
Topics: Aged; Coma; Crime; Humans; Lorazepam; Male; Oxazepam; Periodicity; Poisoning; Spouses | 2004 |
Effect of temperature on enantiomer separation of oxzepam and lorazepam by high-performance liquid chromatography on a beta-cyclodextrin derivatized bonded chiral stationary phase.
Topics: Anti-Anxiety Agents; beta-Cyclodextrins; Chromatography, High Pressure Liquid; Cyclodextrins; Lorazepam; Oxazepam; Spectrophotometry, Ultraviolet; Stereoisomerism; Temperature; Thermodynamics | 2004 |
Chromatographic analysis of allosteric effects between ibuprofen and benzodiazepines on human serum albumin.
Topics: Allosteric Regulation; Benzodiazepines; Chromatography, Affinity; Humans; Ibuprofen; Kinetics; Lorazepam; Models, Chemical; Oxazepam; Serum Albumin; Thermodynamics | 2006 |
Application of polymeric surfactants in micellar electrokinetic chromatography-electrospray ionization mass spectrometry of benzodiazepines and benzoxazocine chiral drugs.
Topics: Benzodiazepines; Chromatography, Micellar Electrokinetic Capillary; Lorazepam; Nefopam; Oxazepam; Polymers; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Surface-Active Agents | 2006 |
Optimization of 12 chiral analytes with 8 polymeric surfactants.
Topics: Alprenolol; Amino Acids; Benzodiazepinones; Buffers; Diamines; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Lorazepam; Naphthalenes; Naphthols; Organophosphates; Oxazepam; Oxprenolol; Propanolamines; Propranolol; Stereoisomerism; Surface-Active Agents; Temazepam | 2008 |
Quantitation of benzodiazepines in blood and urine using gas chromatography-mass spectrometry (GC-MS).
Topics: Alprazolam; Benzodiazepines; Diazepam; Gas Chromatography-Mass Spectrometry; Humans; Lorazepam; Nordazepam; Oxazepam; Solid Phase Extraction; Triazolam | 2010 |
Simultaneous determination and quantification of 12 benzodiazepines in serum or whole blood using UPLC/MS/MS.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Chromatography, Liquid; Clonazepam; Flunitrazepam; Humans; Lorazepam; Midazolam; Nordazepam; Oxazepam; Reproducibility of Results; Tandem Mass Spectrometry | 2010 |
Kinetic and conformational studies of adenosine deaminase upon interaction with oxazepam and lorazepam.
Topics: Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Anti-Anxiety Agents; Anticonvulsants; Cattle; Circular Dichroism; Computer Simulation; Enzyme Inhibitors; Hypnotics and Sedatives; Intestinal Mucosa; Kinetics; Ligands; Lorazepam; Models, Molecular; Oxazepam; Protein Conformation; Spectrometry, Fluorescence; Structure-Activity Relationship; Temperature | 2010 |
Quantification of total and unbound concentrations of lorazepam, oxazepam and temazepam in human plasma by ultrafiltration and LC-MS/MS.
Topics: Anti-Anxiety Agents; Calibration; Chromatography, Liquid; Hemofiltration; Humans; Lorazepam; Oxazepam; Tandem Mass Spectrometry; Temazepam | 2011 |
Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects.
Topics: Adolescent; Adult; Age Factors; Aged; Female; Humans; Lorazepam; Male; Middle Aged; Oxazepam; Protein Binding; Serum Albumin; Temazepam; Young Adult | 2011 |
Sensitive UPLC-MS-MS assay for 21 benzodiazepine drugs and metabolites, zolpidem and zopiclone in serum or plasma.
Topics: Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Humans; Liquid-Liquid Extraction; Lorazepam; Mass Spectrometry; Nordazepam; Oxazepam; Piperazines; Plasma; Pyridines; Serum; Specimen Handling; Tandem Mass Spectrometry; Temazepam; Triazolam; Zolpidem | 2012 |
Evaluation of abalone β-glucuronidase substitution in current urine hydrolysis procedures.
Topics: Analgesics, Opioid; Animals; Benzodiazepines; Cannabinoids; Codeine; Cost-Benefit Analysis; Escherichia coli; Gastropoda; Glucuronidase; Helix, Snails; Hydrolysis; Lorazepam; Morphine Derivatives; Oxazepam; Specimen Handling; Urinalysis | 2014 |
Influence of central nervous system-acting drugs on results of cognitive testing in geriatric inpatients.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antidepressive Agents; Benzodiazepines; Central Nervous System Agents; Cognition Disorders; Diazepam; Female; Hospitalization; Humans; Hypnotics and Sedatives; Lorazepam; Male; Mental Status Schedule; Oxazepam | 2014 |
Rapid enzymatic hydrolysis using a novel recombinant β-glucuronidase in benzodiazepine urinalysis.
Topics: Benzodiazepines; Chromatography, High Pressure Liquid; Glucuronidase; Glucuronides; Humans; Hydrolysis; Lorazepam; Oxazepam; Tandem Mass Spectrometry; Temazepam; Urinalysis | 2014 |
Investigation of the effect of mobile phase composition on selectivity using a solvent-triangle based approach in achiral SFC.
Topics: 1-Propanol; Acetonitriles; Benzodiazepines; Chromatography, Supercritical Fluid; Diazepam; Drug Contamination; Ethanol; Furans; Hydrogen Bonding; Lorazepam; Methanol; Multivariate Analysis; Organic Chemicals; Oxazepam; Principal Component Analysis; Reproducibility of Results; Silicon Dioxide; Solvents; Temazepam | 2017 |
Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.
Topics: Adult; Benzodiazepines; Chromatography, Liquid; Designer Drugs; Humans; Lorazepam; Male; Microsomes, Liver; Oxazepam; Substance-Related Disorders; Tandem Mass Spectrometry | 2017 |
Postmortem Analysis of Benzodiazepines in Human Bone by Gas Chromatography-Mass Spectrometry.
Topics: Alprazolam; Autopsy; Benzodiazepines; Chromatography, Liquid; Clonazepam; Diazepam; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Liquid-Liquid Extraction; Lorazepam; Nordazepam; Oxazepam; Tandem Mass Spectrometry | 2021 |
Construction and Verification of Physiologically Based Pharmacokinetic Models for Four Drugs Majorly Cleared by Glucuronidation: Lorazepam, Oxazepam, Naloxone, and Zidovudine.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Cell Culture Techniques; Cells, Cultured; Coculture Techniques; Datasets as Topic; Female; Glucuronides; Glucuronosyltransferase; Hepatocytes; Humans; Intestines; Kidney; Liver; Lorazepam; Male; Metabolic Clearance Rate; Microsomes, Liver; Middle Aged; Models, Biological; Naloxone; Oxazepam; Young Adult; Zidovudine | 2020 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |